1. Home
  2. LXRX vs MBI Comparison

LXRX vs MBI Comparison

Compare LXRX & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • MBI
  • Stock Information
  • Founded
  • LXRX 1995
  • MBI 1973
  • Country
  • LXRX United States
  • MBI United States
  • Employees
  • LXRX N/A
  • MBI N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • MBI Property-Casualty Insurers
  • Sector
  • LXRX Health Care
  • MBI Finance
  • Exchange
  • LXRX Nasdaq
  • MBI Nasdaq
  • Market Cap
  • LXRX 428.8M
  • MBI 377.2M
  • IPO Year
  • LXRX 2000
  • MBI 1987
  • Fundamental
  • Price
  • LXRX $1.09
  • MBI $6.92
  • Analyst Decision
  • LXRX Buy
  • MBI Buy
  • Analyst Count
  • LXRX 5
  • MBI 1
  • Target Price
  • LXRX $3.23
  • MBI $8.00
  • AVG Volume (30 Days)
  • LXRX 1.6M
  • MBI 455.5K
  • Earning Date
  • LXRX 11-11-2025
  • MBI 11-06-2025
  • Dividend Yield
  • LXRX N/A
  • MBI N/A
  • EPS Growth
  • LXRX N/A
  • MBI N/A
  • EPS
  • LXRX N/A
  • MBI N/A
  • Revenue
  • LXRX $58,432,000.00
  • MBI $108,000,000.00
  • Revenue This Year
  • LXRX N/A
  • MBI N/A
  • Revenue Next Year
  • LXRX N/A
  • MBI N/A
  • P/E Ratio
  • LXRX N/A
  • MBI N/A
  • Revenue Growth
  • LXRX 1504.83
  • MBI 285.71
  • 52 Week Low
  • LXRX $0.28
  • MBI $3.28
  • 52 Week High
  • LXRX $2.18
  • MBI $8.26
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 47.78
  • MBI 45.59
  • Support Level
  • LXRX $1.03
  • MBI $7.32
  • Resistance Level
  • LXRX $1.19
  • MBI $7.84
  • Average True Range (ATR)
  • LXRX 0.06
  • MBI 0.35
  • MACD
  • LXRX -0.00
  • MBI -0.17
  • Stochastic Oscillator
  • LXRX 35.29
  • MBI 5.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.

Share on Social Networks: